BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32212919)

  • 1. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
    Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
    Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
    [No Abstract]   [Full Text] [Related]  

  • 2. The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience.
    Campi I; Covelli D; Moran C; Fugazzola L; Cacciatore C; Orlandi F; Gallone G; Chatterjee K; Beck-Peccoz P; Persani L
    Front Endocrinol (Lausanne); 2020; 11():432. PubMed ID: 32733382
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.
    Macchia E; Lombardi M; Raffaelli V; Piaggi P; Macchia L; Scattina I; Martino E
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):921-8. PubMed ID: 25040256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders.
    Tagami T
    Endocr J; 2021 May; 68(5):509-517. PubMed ID: 33827995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review.
    Yoon JH; Choi W; Park JY; Hong AR; Kim SS; Kim HK; Kang HC
    BMC Endocr Disord; 2021 Aug; 21(1):177. PubMed ID: 34461869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
    De Herdt C; Philipse E; De Block C
    Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):306-314. PubMed ID: 37144621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
    Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
    Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).
    Teng X; Jin T; Brent GA; Wu A; Teng W; Shan Z
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2511-4. PubMed ID: 25867808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma).
    Yu B; Zhang Z; Song H; Chi Y; Shi C; Xu M
    Med Sci Monit; 2017 Apr; 23():1947-1955. PubMed ID: 28434012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone.
    Bogazzi F; Manetti L; Tomisti L; Rossi G; Cosci C; Sardella C; Bartalena L; Gasperi M; Macchia E; Vitti P; Martino E
    Thyroid; 2006 Oct; 16(10):989-95. PubMed ID: 17042684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma.
    Tagami T; Usui T; Shimatsu A; Beniko M; Yamamoto H; Moriyama K; Naruse M
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E948-52. PubMed ID: 21430027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-secreting pituitary adenomas: diagnosis and management of patients from one Chinese center.
    Zhao W; Ye H; Li Y; Zhou L; Lu B; Zhang S; Wen J; Li S; Yang Y; Hu R
    Wien Klin Wochenschr; 2012 Oct; 124(19-20):678-84. PubMed ID: 23053568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumours: TSH-secreting adenomas.
    Beck-Peccoz P; Persani L; Mannavola D; Campi I
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):597-606. PubMed ID: 19945025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
    Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
    Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary hyperplasia mimicking thyrotropin-producing pituitary adenoma in the patient with resistance to thyroid hormone: a case report.
    Suntornlohanakul O; Sriphrapradang C
    Int J Neurosci; 2022 Feb; 132(2):207-211. PubMed ID: 32727243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
    Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
    J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.